中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
12期
76-77
,共2页
左炔诺孕酮宫内缓释系统(LNG-IUS)%子宫腺肌症%安全性%可行性
左炔諾孕酮宮內緩釋繫統(LNG-IUS)%子宮腺肌癥%安全性%可行性
좌결낙잉동궁내완석계통(LNG-IUS)%자궁선기증%안전성%가행성
Levonorgestrel releasing intrauterine system (LNG-IUS)%Adenomyosis%Safety%Feasibility
目的：探讨左炔诺孕酮宫内缓释系统(LNG-IUS)在治疗子宫腺肌症的安全性和可行性。方法回顾性分析100例子宫腺肌症患者的临床资料。结果放置3个月后，患者的痛经现象得到明显的改善，月经量减少（P＜0.05）；子宫体积12个月内无明显变化（P＜0.05），患者的不良反应较少且症状较轻。结论左炔诺孕酮宫内缓释系统（LNG-IUS）治疗子宫腺肌症的安全性和可行性都较高。
目的：探討左炔諾孕酮宮內緩釋繫統(LNG-IUS)在治療子宮腺肌癥的安全性和可行性。方法迴顧性分析100例子宮腺肌癥患者的臨床資料。結果放置3箇月後，患者的痛經現象得到明顯的改善，月經量減少（P＜0.05）；子宮體積12箇月內無明顯變化（P＜0.05），患者的不良反應較少且癥狀較輕。結論左炔諾孕酮宮內緩釋繫統（LNG-IUS）治療子宮腺肌癥的安全性和可行性都較高。
목적：탐토좌결낙잉동궁내완석계통(LNG-IUS)재치료자궁선기증적안전성화가행성。방법회고성분석100례자궁선기증환자적림상자료。결과방치3개월후，환자적통경현상득도명현적개선，월경량감소（P＜0.05）；자궁체적12개월내무명현변화（P＜0.05），환자적불량반응교소차증상교경。결론좌결낙잉동궁내완석계통（LNG-IUS）치료자궁선기증적안전성화가행성도교고。
Objective To explore the safety and feasibility of LNG-IUS in the treatment of adenomyosis.Methods A retrospective analysis was performed on clinical data of 100 patients with adenomyosis. Results Placed after 3 months, the phenomenon of dysmenorrhea patients improved obviously, and menstrual reduction (P<0.05); there was no significant change in uterine volume within 12 months (P>0.05), patients with less adverse reactions and mild symptoms.Conclusion Levonorgestrel releasing intrauterine system (LNG-IUS) safety and feasibility for the treatment of adenomyosis are higher.
